USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Feb 22, 2022 | Dec 2021 | $-0.33 | - | $-0.21 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Feb 22, 2022 | Dec 2021 | $13.77M | - | $13.77M |
Alimera Sciences's next earnings date is Tuesday, Feb 22, 2022 for the fiscal quarter ending Dec 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $-0.33 | $-0.36 | $-0.30 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $-0.35 | $-0.38 | $-0.32 |
| Dec 2022 | 2 | $-1.09 | $-1.75 | $-0.43 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.33 | $-0.33 | $-0.04 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.35 | $-0.35 | $0.19 |
| Dec 2022 | 0 / 0 | $-1.09 | $-0.84 | $-0.33 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 3 | $13.77M | $13.30M | $14.50M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $58.86M | $58.00M | $59.72M |
| Dec 2022 | 3 | $61.10M | $55.50M | $65.30M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Oct 28, 2021 | Sep 2021 | $-0.52 | - | - |
| Aug 13, 2021 | Jun 2021 | $-0.31 | $0.71 | 329.03% |
| Apr 28, 2021 | Mar 2021 | $-0.45 | $-0.66 | -44.88% |
| Feb 24, 2021 | Dec 2020 | $-0.14 | $-0.21 | -56.15% |
| Oct 28, 2020 | Sep 2020 | $-0.29 | $-0.17 | 39.10% |
| Jul 29, 2020 | Jun 2020 | $-1.25 | $-0.53 | 57.78% |
| Apr 29, 2020 | Mar 2020 | $-0.46 | $-0.22 | 50.70% |
| Feb 26, 2020 | Dec 2019 | $-0.29 | $0.07 | 124.86% |
| Oct 29, 2019 | Sep 2019 | $-0.55 | $-0.63 | -15.36% |
| Jul 29, 2019 | Jun 2019 | $-0.50 | $-1.04 | -107.60% |
| Apr 29, 2019 | Mar 2019 | $-0.63 | $-0.57 | 9.33% |
| Feb 19, 2019 | Dec 2018 | $-0.45 | $-0.12 | 74.00% |
| Nov 6, 2018 | Sep 2018 | $-0.94 | $-0.59 | 37.60% |
| Jul 30, 2018 | Jun 2018 | $-0.98 | $-0.85 | 12.77% |
| May 3, 2018 | Mar 2018 | $-0.53 | $-1.20 | -128.57% |
| Feb 28, 2018 | Dec 2017 | $-0.65 | $-1.57 | -141.62% |
| Nov 1, 2017 | Sep 2017 | $-0.65 | $-1.78 | -174.15% |
| Aug 2, 2017 | Jun 2017 | $-0.95 | $-0.64 | 32.26% |
| May 8, 2017 | Mar 2017 | $-1.50 | $-1.50 | - |
| Mar 1, 2017 | Dec 2016 | $-1.35 | $-1.50 | -11.11% |
| Nov 2, 2016 | Sep 2016 | $-1.65 | $-2.30 | -39.45% |
| Aug 3, 2016 | Jun 2016 | $-2.48 | $-2.55 | -3.03% |
| May 4, 2016 | Mar 2016 | $-2.85 | $-3.30 | -15.79% |
| Mar 3, 2016 | Dec 2015 | $-3.50 | $-3.60 | -2.86% |
| Nov 5, 2015 | Sep 2015 | $-0.21 | $-0.03 | 85.71% |
| Aug 10, 2015 | Jun 2015 | $-0.22 | $-0.19 | 13.64% |
| May 7, 2015 | Mar 2015 | $-0.24 | $-0.22 | 8.33% |
| Mar 4, 2015 | Dec 2014 | $-0.17 | $-0.23 | -35.29% |
| Nov 6, 2014 | Sep 2014 | $-0.70 | $-0.17 | 75.71% |
| Aug 7, 2014 | Jun 2014 | $-3.37 | $0.60 | 117.80% |
| May 8, 2014 | Mar 2014 | $-3.67 | $-3.00 | 18.26% |
| Feb 27, 2014 | Dec 2013 | $-4.28 | $-6.30 | -47.20% |
| Nov 11, 2013 | Sep 2013 | $-4.42 | $-3.90 | 11.76% |
| Aug 12, 2013 | Jun 2013 | $-3.60 | $-4.50 | -25.00% |
| May 9, 2013 | Mar 2013 | $-3.97 | $-4.05 | -2.02% |
| Mar 21, 2013 | Dec 2012 | $-3.45 | $-2.55 | 26.09% |
| Nov 7, 2012 | Sep 2012 | $-2.70 | $-2.55 | 5.56% |
| Aug 9, 2012 | Jun 2012 | $-2.44 | $-2.25 | 7.79% |
| May 11, 2012 | Mar 2012 | $-1.86 | $-2.10 | -12.90% |
| Mar 8, 2012 | Dec 2011 | $-3.34 | $-2.85 | 14.67% |
| Nov 3, 2011 | Sep 2011 | $-2.85 | $-3.15 | -10.53% |
| Aug 4, 2011 | Jun 2011 | $-2.91 | $-2.55 | 12.37% |
| May 5, 2011 | Mar 2011 | $-2.92 | $-2.25 | 22.95% |
| Feb 10, 2011 | Dec 2010 | $-3.34 | $-3.00 | 10.18% |
| Nov 4, 2010 | Sep 2010 | $-3.94 | $-3.00 | 23.86% |
| Aug 12, 2010 | Jun 2010 | $-3.94 | $-4.05 | -2.79% |
| Jun 3, 2010 | Mar 2010 | $-7.35 | $-65.55 | -791.84% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Feb 24, 2021 | Dec 2020 | $-0.91 | $-1.14 | - |
| Feb 26, 2020 | Dec 2019 | $-2.74 | $-2.17 | - |
| Feb 19, 2019 | Dec 2018 | $0.24 | $-2.75 | - |
| Feb 28, 2018 | Dec 2017 | $-0.28 | $-5.50 | - |
| Mar 1, 2017 | Dec 2016 | - | $-9.65 | - |
| Mar 3, 2016 | Dec 2015 | - | $-4.04 | - |
| Mar 4, 2015 | Dec 2014 | - | $-2.80 | - |
| Feb 27, 2014 | Dec 2013 | - | $-18.75 | - |
| Mar 21, 2013 | Dec 2012 | - | $-9.45 | - |
| Mar 8, 2012 | Dec 2011 | - | $-10.80 | - |
| Feb 10, 2011 | Dec 2010 | - | $-75.60 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Oct 28, 2021 | Sep 2021 | $12.37M | - | - |
| Aug 13, 2021 | Jun 2021 | $16.04M | $21.70M | 1.35% |
| Apr 28, 2021 | Mar 2021 | $12.07M | $11.21M | 0.93% |
| Feb 24, 2021 | Dec 2020 | $13.43M | $13.77M | 1.03% |
| Oct 28, 2020 | Sep 2020 | $10.89M | $12.47M | 1.15% |
| Jul 29, 2020 | Jun 2020 | $6.58M | $10.04M | 1.53% |
| Apr 29, 2020 | Mar 2020 | $13.76M | $14.54M | 1.06% |
| Feb 26, 2020 | Dec 2019 | $14.27M | $17.35M | 1.22% |
| Oct 29, 2019 | Sep 2019 | $12.79M | $12.85M | 1.00% |
| Jul 29, 2019 | Jun 2019 | $12.99M | $10.86M | 0.84% |
| Apr 29, 2019 | Mar 2019 | $12.28M | $12.89M | 1.05% |
| Feb 19, 2019 | Dec 2018 | $12.97M | $15.11M | 1.17% |
| Nov 6, 2018 | Sep 2018 | $10.92M | $11.14M | 1.02% |
| Jul 30, 2018 | Jun 2018 | $10.75M | $10.92M | 1.02% |
| May 3, 2018 | Mar 2018 | $10.29M | $9.80M | 0.95% |
| Feb 28, 2018 | Dec 2017 | $12.17M | $9.14M | 0.75% |
| Nov 1, 2017 | Sep 2017 | - | $9.78M | - |
| Aug 2, 2017 | Jun 2017 | - | $10.37M | - |
| May 8, 2017 | Mar 2017 | - | $6.62M | - |
| Mar 1, 2017 | Dec 2016 | - | $10.68M | - |
| Nov 2, 2016 | Sep 2016 | - | $8.30M | - |
| Aug 3, 2016 | Jun 2016 | - | $9.56M | - |
| May 4, 2016 | Mar 2016 | - | $5.80M | - |
| Mar 3, 2016 | Dec 2015 | - | $5.82M | - |
| Nov 5, 2015 | Sep 2015 | - | $6.90M | - |
| Aug 10, 2015 | Jun 2015 | - | $5.78M | - |
| May 7, 2015 | Mar 2015 | - | $3.94M | - |
| Mar 4, 2015 | Dec 2014 | - | $1.74M | - |
| Nov 6, 2014 | Sep 2014 | - | $2.41M | - |
| Aug 7, 2014 | Jun 2014 | - | $2.19M | - |
| May 8, 2014 | Mar 2014 | - | $2.08M | - |
| Feb 27, 2014 | Dec 2013 | - | $935.00K | - |
| Nov 11, 2013 | Sep 2013 | - | $758.00K | - |
| Aug 12, 2013 | Jun 2013 | - | $179.00K | - |
| May 9, 2013 | Mar 2013 | - | $0.00 | - |
| Mar 21, 2013 | Dec 2012 | - | $0.00 | - |
| Nov 7, 2012 | Sep 2012 | - | $0.00 | - |
| Aug 9, 2012 | Jun 2012 | - | $0.00 | - |
| May 11, 2012 | Mar 2012 | - | $0.00 | - |
| Mar 8, 2012 | Dec 2011 | - | $0.00 | - |
| Nov 3, 2011 | Sep 2011 | - | $0.00 | - |
| Aug 4, 2011 | Jun 2011 | - | $0.00 | - |
| May 5, 2011 | Mar 2011 | - | $0.00 | - |
| Feb 10, 2011 | Dec 2010 | - | $0.00 | - |
| Nov 4, 2010 | Sep 2010 | - | $0.00 | - |
| Aug 12, 2010 | Jun 2010 | - | $0.00 | - |
| Jun 3, 2010 | Mar 2010 | - | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Feb 24, 2021 | Dec 2020 | $50.49M | $50.82M | 0.65% |
| Feb 26, 2020 | Dec 2019 | $50.85M | $53.94M | 6.08% |
| Feb 19, 2019 | Dec 2018 | $44.82M | $46.97M | 4.80% |
| Feb 28, 2018 | Dec 2017 | $38.91M | $35.91M | -7.70% |
| Mar 1, 2017 | Dec 2016 | - | $34.33M | - |
| Mar 3, 2016 | Dec 2015 | - | $22.44M | - |
| Mar 4, 2015 | Dec 2014 | - | $8.42M | - |
| Feb 27, 2014 | Dec 2013 | - | $1.87M | - |
| Mar 21, 2013 | Dec 2012 | - | $0.00 | - |
| Mar 8, 2012 | Dec 2011 | - | $0.00 | - |
| Feb 10, 2011 | Dec 2010 | - | - | - |
ALIM's next earnings date is Tuesday, Feb 22, 2022 for the fiscal quarter ending Dec 31, 2021.
According to analysts, the average EPS estimation for Alimera Sciences's next quarterly earnings is $-0.33, with a low EPS estimation of $-0.36, and a high estimation of $-0.30.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.33, the last 2 month trend is $-0.33, and the 3 month trend is $-0.04.
Based on analysts, the average revenue estimation is $13.77M, with a low revenue estimation of $13.30M, and a high estimation of $14.50M.
Alimera Sciences's previous earnings date was Oct 28, 2021 for its fiscal quarter ended Sep 30, 2021.
Alimera Sciences's previous annual earnings date was Feb 24, 2021 for its fiscal year ended Dec 31, 2020.
ALIM's earnings per share (EPS) was $-1.14, missing the consensus analysts forecast of $-0.91 by 25.00% , and higher than the previous year's EPS (Dec 2019) by -47.62%.
Revenues were $50.82M, better than the forecast of $50.49M by 0.65%, and down by -5.79% from previous year's revenue.
The company reported a net income of $-5.34M.
Alimera Sciences reported a free cash flow of $-2.81M for its fiscal year, compared to $-4.33M a year ago.
The company ended the fiscal year with $44.50M in total debt, an increase of 13.00% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
